Design and Evaluation of PLGA-Based Hybrid Nanoparticles for Nasal Paclitaxel Delivery: Formulation Optimization, Barrier Transport, and Cytotoxicity Assessment.

Sousa ACDS, Oda CMR, Branco de Barros AL, de Freitas Marques MB, Wong CYJ, Ong HX, Traini D, Leite EA

Open source

DOI
10.1021/acsomega.6c05503
Published
2026 Sep 15
Container
ACS omega
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1021/acsomega.6c05503,
  title = {Design and Evaluation of PLGA-Based Hybrid Nanoparticles for Nasal Paclitaxel Delivery: Formulation Optimization, Barrier Transport, and Cytotoxicity Assessment.},
  author = {Sousa ACDS and Oda CMR and Branco de Barros AL and de Freitas Marques MB and Wong CYJ and Ong HX and Traini D and Leite EA},
  year = {2026},
  journal = {ACS omega},
  doi = {10.1021/acsomega.6c05503},
  url = {https://doi.org/10.1021/acsomega.6c05503}
}

RIS

TY  - JOUR
TI  - Design and Evaluation of PLGA-Based Hybrid Nanoparticles for Nasal Paclitaxel Delivery: Formulation Optimization, Barrier Transport, and Cytotoxicity Assessment.
AU  - Sousa ACDS
AU  - Oda CMR
AU  - Branco de Barros AL
AU  - de Freitas Marques MB
AU  - Wong CYJ
AU  - Ong HX
AU  - Traini D
AU  - Leite EA
PY  - 2026
JO  - ACS omega
DO  - 10.1021/acsomega.6c05503
UR  - https://doi.org/10.1021/acsomega.6c05503
ER  - 

APA

ACDS, S., CMR, O., AL, B. D. B., MB, D. F. M., CYJ, W., HX, O., D, T., & EA, L. (2026). Design and Evaluation of PLGA-Based Hybrid Nanoparticles for Nasal Paclitaxel Delivery: Formulation Optimization, Barrier Transport, and Cytotoxicity Assessment.. ACS omega. https://doi.org/10.1021/acsomega.6c05503

Source records